Cartilage Degeneration Overview

Principles

Definition

Cartilage degeneration is a research concept and field of study focused on the biological and mechanical processes that lead to the progressive breakdown and loss of cartilage tissue. This concept investigates the underlying mechanisms, causes, and consequences of this pathological process, which is fundamental to understanding joint health and diseases such as osteoarthritis.

Ontological type

Pathophysiology

Therapeutic Strategies

Risk Factors

Key developments

Key Figures

Mechanobiology Emergence era

Van C. Mow [1] was active at Harvard University [3] and Columbia University [4] during the Mechanobiology Emergence era, shaping cartilage degeneration research. His Biphasic Creep and Stress Relaxation of Articular Cartilage in Compression: Theory and Experiments (1980) [7] introduced a biphasic framework that links fluid flow to matrix deformation, a cornerstone for mechanobiology in this era. Tim Hardingham [2] was affiliated with the University of Cambridge [5] and the University of Bristol [6] during this period. His work, including Hyaluronic acid in cartilage and proteoglycan aggregation [8], Cartilage proteoglycans. Structure and heterogeneity of the protein core and the effects of specific protein modifications on the binding to hyaluronate [9], and Articular cartilage cultured with interleukin 1. Increased release of link protein, hyaluronate-binding region and other proteoglycan fragments [10], advanced understanding of proteoglycan organization and cytokine-mediated matrix vulnerability in mechanically loaded cartilage.

Cytokine–Protease Catabolism era

Benoît De Crombrugghe [1] is associated with Harvard University [3] and the Weizmann Institute of Science [4] during the Cytokine–Protease Catabolism era. His key contributions in this era include the finding that Sox9 is required for cartilage formation [7] and that SOX9 is a potent activator of the chondrocyte-specific enhancer of the Proα1(II) collagen gene [8], which clarified transcriptional control of cartilage matrix synthesis. Steffen Gay [2] is linked to the University of California, San Francisco [5] and Karolinska Institutet [6] during this era. In 2005, his work culminated in Osteoarthritis cartilage histopathology: grading and staging [9], a study that standardizes assessment of cartilage degeneration and helps connect inflammatory–protease–driven changes with disease severity to guide therapeutic targeting.

Regenerative Vesicle Therapies era

Mary B. Goldring [1], associated with Albert Einstein College of Medicine [3] and Cornell University [4], stands at the forefront of cartilage biology and osteoarthritis research during this period. Her key contributions, as reflected in the 2012 paper Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis [7], illuminate how chondrocyte differentiation and cartilage metabolism govern tissue homeostasis and OA progression, underpinning later exosome- and biomaterial-guided strategies. Andrea Barbero [2], with affiliations including Forest Institute [5] and Université Paris Cité [6], has helped shape regenerative approaches to skeletal tissues during this era. His work on engineering a functional bone organ through endochondral ossification [8] demonstrates how developmental bone formation concepts can be leveraged to build multimodal cartilage repair frameworks, advancing cell-free and phenotype-directed therapies.